Vaccitech plc (VACC) Tops Q3 EPS by 62c

Vaccitech plc (NASDAQ: VACC) reported Q3 EPS of $0.22, $0.62 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $6.17 million versus the consensus estimate of $6.7 million.

For earnings history and earnings-related data on Vaccitech plc (VACC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c